Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 05, 2007. The report serves as a notification of a change in major shareholding interests rather than a financial performance report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding shareholder ownership thresholds and contains no financial statement data.
Material Changes
The material change disclosed is a notification from Legal & General Group plc regarding their interest in GlaxoSmithKline plc ordinary shares. The notification indicates that the group's voting rights remain below the 5% threshold following the transaction dated December 03, 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly a compliance filing under DTR 5.8.12 regarding the notification of major interests in shares.
Important Facts for Investors
- Shareholder Notification: Legal & General Group plc notified GSK of its shareholding interest on December 04, 2007, for a transaction dated December 03, 2007.
- Voting Rights Threshold: The total voting rights held by Legal & General Group plc and its subsidiaries (including LGIM and PMC) remain below 5%.
- Specific Holdings: Legal & General Group Plc (L&G) holds 254,504,547 shares (4.61%), and Legal & General Assurance (Pensions Management) Limited (PMC) holds 204,989,570 shares (3.71%).
- Total Voting Base: The notification is based on a total voting rights figure of 5,518,245,946.
- No Financial Data: Investors should not use this filing for financial performance analysis as it contains no revenue or earnings data.